Literature DB >> 18461853

[Adverse drug effect as cause of hospital admission. Common drugs are the major part according to the cross-sectional study].

Ingegerd Odar-Cederlöf1, Per Oskarsson, Gunnar Ohlén, Yohannes Tesfa, Annica Bergendal, Anders Helldén, Ulf Bergman.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18461853

Source DB:  PubMed          Journal:  Lakartidningen        ISSN： 0023-7205


× No keyword cloud information.
  10 in total

Review 1.  Identifying high-risk medication: a systematic literature review.

Authors:  Eva A Saedder; Birgitte Brock; Lars Peter Nielsen; Dorthe K Bonnerup; Marianne Lisby
Journal:  Eur J Clin Pharmacol       Date:  2014-03-27       Impact factor: 2.953

2.  Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey.

Authors:  Jon Brännström; Katarina Hamberg; Lena Molander; Hugo Lövheim; Yngve Gustafson
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

3.  Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study.

Authors:  Anders Helldén; Ulf Bergman; Mia von Euler; Maria Hentschke; Ingegerd Odar-Cederlöf; Gunnar Ohlén
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Which Medication Is the Patient Taking at Admission to the Emergency Ward? Still Unclear Despite the Swedish Prescribed Drug Register.

Authors:  Ida Engqvist; Katja Wyss; Charlotte Asker-Hagelberg; Ulf Bergman; Ingegerd Odar-Cederlöf; Carl-Olav Stiller; Jessica Fryckstedt
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

5.  Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.

Authors:  Cecilia Lenander; Birgitta Elfsson; Birgitta Danielsson; Patrik Midlöv; Jan Hasselström
Journal:  Scand J Prim Health Care       Date:  2014-10-27       Impact factor: 2.581

6.  Development of a computerised decisions support system for renal risk drugs targeting primary healthcare.

Authors:  Anders Helldén; Fadiea Al-Aieshy; Pia Bastholm-Rahmner; Ulf Bergman; Lars L Gustafsson; Hans Höök; Susanne Sjöviker; Anders Söderström; Ingegerd Odar-Cederlöf
Journal:  BMJ Open       Date:  2015-07-06       Impact factor: 2.692

7.  Importance of potentially inappropriate medications, number of chronic conditions and medications for the risk of hospitalisation in elderly in Sweden: a case-control study.

Authors:  Kristine Thorell; Patrik Midlöv; Johan Fastbom; Anders Halling
Journal:  BMJ Open       Date:  2019-09-27       Impact factor: 2.692

8.  Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly.

Authors:  Anders Helldén; Ingegerd Odar-Cederlöf; Göran Nilsson; Susanne Sjöviker; Anders Söderström; Mia von Euler; Gunnar Ohlén; Ulf Bergman
Journal:  BMJ Open       Date:  2013-04-11       Impact factor: 2.692

9.  SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions.

Authors:  Pär Hallberg; Qun-Ying Yue; Erik Eliasson; Håkan Melhus; Joel Ås; Mia Wadelius
Journal:  Pharmacogenomics J       Date:  2020-01-17       Impact factor: 3.550

10.  Elderly at risk in care transitions When discharge summaries are poorly transferred and used -a descriptive study.

Authors:  Gabriella Caleres; Åsa Bondesson; Patrik Midlöv; Sara Modig
Journal:  BMC Health Serv Res       Date:  2018-10-11       Impact factor: 2.655
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.